PRÉNATAL
Natural health product licensed in Canada
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80095858
- Status
- Active licence
- Licence date
- 2 December 2019
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Fer: up to 27 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Iode: up to 220 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 1.4 mg | 1,400 µg |
| Niacinamide Source : Niacinamide | 18 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 85 mg | 85,000 µg |
| Vitamine A Source : Acétate de vitamine A | 1,000 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 400 UI | 10 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 30 UI | Not calculated |
| Thiamine Source : Mononitrate de thiamine | 1.4 mg | 1,400 µg |
| Bêta-carotène Source : bêta-carotène | 1,500 mcg | Not calculated |
| Fer Source : Fumarate de fer (II) | 27 mg | 27,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 1.9 mg | 1,900 µg |
| Cuivre Source : Sulfate de cuivre (II) | 1 mg | 1,000 µg |
| Iode Source : Iodate de potassium | 220 mcg | 220 µg |
| Biotine Source : Biotine | 30 mcg | 30 µg |
| Zinc Source : Oxyde de zinc | 7.5 mg | 7,500 µg |
Non-medicinal ingredients
Croscarmellose de sodium, Stéarate de magnésium, Talc, Maltodextrine, Poly(alcool vinylique), Laque d'aluminium FD&C Rouge n° 40, Hypromellose, Poly(dextrose), Poly(éthylène glycol), Amidon de maïs, Dioxyde de silicium, Carboxyméthylcellulose de sodium, Cellulose microcristalline, Dioxyde de titane, Acide l-tartrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Aide à réduire les risques de malformations du tube neural lorsqu'il est pris quotidiennement au moins trois mois avant le début de la grossesse et pendant le début de la grossesse. Aide à soutenir le développement précoce normal du foetus (cerveau et moelle épinière). Source d'une/de vitamine(s)/minéral(minéraux)/vitamine(s) et minéral(minéraux) qui contribue(nt) à la croissance et au développement normaux. Supplément de multivitamines et multiminéraux.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Garder hors de portée des enfants. Ce contenant contient assez de médicament pouvant causer des torts sérieux à un enfant.
- Effets indésirables connus
Cesser l'utilisation si une hypersensibilité se manifeste.
Source
Official Health Canada record, licence 80095858
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.